THC Therapeutics (THC Therapeutics) YoY EBITDA Growth : -100.00% (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. THC Therapeutics's YoY EBITDA Growth for the quarter that ended in Jul. 2023 was -100.00%.

THC Therapeutics's EBITDA per Share for the three months ended in Jul. 2023 was $0.00.

THC Therapeutics YoY EBITDA Growth Historical Data

The historical data trend for THC Therapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics YoY EBITDA Growth Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

YoY EBITDA Growth

Get a 7-Day Free Trial

-244.29

94.99

34.88

25.00

78.57

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
YoY EBITDA Growth	Get a 7-Day Free Trial															135.71	-357.14	360.00	116.67	-100.00

THC Therapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

THC Therapeutics's YoY EBITDA Growth for the fiscal year that ended in Jul. 2023 is calculated as:

	YoY EBITDA Growth (A: Jul. 2023 )
=	(EBITDA per Share (A: Jul. 2023 )	-	EBITDA per Share (A: Jul. 2022 ))	/	\| EBITDA per Share (A: Jul. 2022 ) \|
=	(-0.009	-	-0.042)	/	\| -0.042 \|
=	78.57 %

THC Therapeutics's YoY EBITDA Growth for the quarter that ended in Jul. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jul. 2023 )
=	(EBITDA per Share (Q: Jul. 2023 )	-	EBITDA per Share (Q: Jul. 2022 ))	/	\| EBITDA per Share (Q: Jul. 2022 )) \|
=	(-0	-	0.01)	/	\| 0.01 \|
=	-100.00 %

THC Therapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX